Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration

Nature Communications

Volumn 4, Issue , 2013, Pages

  Kondo, Naohide ^a   Katsuno, Masahisa ^a   Adachi, Hiroaki ^a   Minamiyama, Makoto ^a   Doi, Hideki ^a   Matsumoto, Shinjiro ^a   Miyazaki, Yu ^a   Iida, Madoka ^a   Tohnai, Genki ^a   Nakatsuji, Hideaki ^a   Ishigaki, Shinsuke ^a   Fujioka, Yusuke ^a   Watanabe, Hirohisa ^a   Tanaka, Fumiaki ^a   Nakai, Akira ^b   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; POLYGLUTAMINE; DNA BINDING PROTEIN; HEAT SHOCK PROTEIN; HSF1 PROTEIN, MOUSE; MUTANT PROTEIN; PEPTIDE; TRANSCRIPTION FACTOR;

ADULT; ANDROGEN; BRAIN; GENE EXPRESSION; HEAT SHOCK; LESION; NEUROLOGY; PATHOLOGY; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HETEROZYGOTE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; KENNEDY DISEASE; LIVER; MOUSE; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; VISUAL CORTEX; AGED; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; MIDDLE AGED; MOTOR CORTEX; MOUSE MUTANT; MUSCLE ATROPHY; NEOSTRIATUM; NERVE CELL; PATHOLOGY; TRANSGENE;

AGED; ANIMALS; CENTRAL NERVOUS SYSTEM; DNA-BINDING PROTEINS; HEAT-SHOCK PROTEINS; HEK293 CELLS; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MOTOR CORTEX; MUSCULAR DISORDERS, ATROPHIC; MUTANT PROTEINS; NEOSTRIATUM; NERVE DEGENERATION; NEURONS; ORGAN SPECIFICITY; PEPTIDES; PITUITARY GLAND; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS; TRANSGENES;

MLCS; MLOWN;

EID: 84879154600     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2417     Document Type: Article

References (52)

1. Morimoto, R. I. & Santoro, M. G. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat. Biotechnol. 16, 833-838 (1998). (Pubitemid 28405852)
2. Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332 (2011).
3. Wyttenbach, A. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J. Mol. Neurosci. 23, 69-96 (2004).
4. Muchowski, P. J. & Wacker, J. L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11-22 (2005). (Pubitemid 40052135)
5. Hoshino, T. et al. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. J. Neurosci. 31, 5225-5234 (2011).
6. Gifondorwa, D. J. et al. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 27, 13173-13180 (2007). (Pubitemid 350220502)
7. Wacker, J. L. et al. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 11, 1215-1222 (2004).
8. Bailey, C. K., Andriola, I. F., Kampinga, H. H. & Merry, D. E. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11, 515-523 (2002). (Pubitemid 34257488)
9. Chan, H. Y. et al. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11, 2895-2904 (2002).
10. Adachi, H. et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23, 2203-2211 (2003). (Pubitemid 36368908)
11. Katsuno, M. et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl Acad. Sci. USA 102, 16801-16806 (2005). (Pubitemid 41688857)
12. Anckar, J. & Sistonen, L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Ann. Rev. Biochem. 80, 1089-1115 (2011).
13. Holmberg, M. et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913-918 (1998). (Pubitemid 28221256)
14. Yamada, M. et al. Polyglutamine disease: recent advances in the neuropathology of dentatorubal-pallidoluysian atrophy. Neuropathology 26, 346-351 (2006). (Pubitemid 44086839)
15. Tanaka, M. et al. Intra-and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases. J. Biol. Chem. 276, 45470-45475 (2001).
16. Okazawa, H. et al. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34, 701-713 (2002). (Pubitemid 34628734)
17. Subramaniam, S., Sixt, K. M., Barrow, R. & Snyder, S. H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330 (2009).
18. Tagawa, K. et al. The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes. J. Neurosci. 27, 868-880 (2007). (Pubitemid 46174507)
19. Yamanaka, T. et al. Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J. 27, 827-839 (2008). (Pubitemid 351417169)
20. Adachi, H. et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128, 659-670 (2005). (Pubitemid 40380200)
21. Yamada, M. et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann. Neurol. 49, 14-23 (2001). (Pubitemid 32163001)
22. Nucifora, F. C. et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428 (2001). (Pubitemid 32231807)
23. Minamiyama, M. et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183-1192 (2004). (Pubitemid 38787000)
24. Ranganathan, S. et al. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 27-42 (2009).
25. Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843-854 (2002).
26. Takeyama, K. et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35, 855-864 (2002).
27. Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768-773 (2003). (Pubitemid 36749228)
28. Chevalier-Larsen, E. S. et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24, 4778-4786 (2004). (Pubitemid 38668202)
29. Kennedy, W. R., Alter, M. & Sung, J. H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671-680 (1968).
30. Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112(Part 1): 209-232 (1989). (Pubitemid 19056483)
31. Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Ann. Rev. Neurosci. 30, 575-621 (2007). (Pubitemid 47218768)
32. Doyu, M. et al. Androgen receptor mRNA with increased size of tandem CAG repeat is widely expressed in the neuronal and nonneuronal tissues of X-linked recessive bulbospinal neuronopathy. J. Neurol. Sci. 127, 43-47 (1994). (Pubitemid 24372522)
33. Hayashida, N. et al. Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT. EMBO J. 29, 3459-3469 (2010).
34. Nagai, Y. et al. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332-340 (2007). (Pubitemid 46608340)
35. Mason, Jr P. B. & Lis, J. T. Cooperative and competitive protein interactions at the hsp70 promoter. J. Biol. Chem. 272, 33227-33233 (1997). (Pubitemid 28023670)
36. Li, Q. et al. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J. 17, 6300-6315 (1998). (Pubitemid 28497802)
37. Pore, N. et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 15, 4841-4853 (2004). (Pubitemid 39392201)
38. Fujimoto, M. et al. Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J. Biol. Chem. 280, 34908-34916 (2005). (Pubitemid 41504625)
39. Kobayashi, Y. et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 275, 8772-8778 (2000). (Pubitemid 30180231)
40. Adachi, H. et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J. Neurosci. 27, 5115-5126 (2007). (Pubitemid 46741791)
41. Waza, M. et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088-1095 (2005). (Pubitemid 41486831)
42. La Spada, A. R. et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79 (1991). (Pubitemid 21896702)
43. Nagai, Y., Fujikake, N., Popiel, H. A. & Wada, K. Induction of molecular chaperones as therapeutic strategy for the polyglutamine diseases. Curr. Pharm. Biotechnol. 11, 188-197 (2010).
44. Rimoldi, M., Servadio, A. & Zimarino, V. Analysis of heat shock transcription factor for suppression of polyglutamine toxicity. Brain Res. Bull. 56, 353-362 (2001). (Pubitemid 33062361)
45. Okabe, M. et al. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319 (1997). (Pubitemid 27199450)
46. Mieulet, V. et al. S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am. J. Physiol. Cell Physiol. 293, C712-C722 (2007). (Pubitemid 47235195)
47. Tokui, K. et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum. Mol. Genet. 18, 898-910 (2009).
48. Marinova, Z. et al. Valproic acid induces functional heat-shock protein 70 via Class II histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. J. Neurochem. 111, 976-987 (2009).
49. Yamanaka, T. et al. Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction. Hum. Mol. Genet. 19, 2099-2112 (2010).
50. Hsu, A. L. et al. Regulation of aging and age-related disease by DAF-16 and heat shock factor. Science 300, 1142-1145 (2003).
51. Inouye, S. et al. Heat shock transcription factor 1 opens chromatin structure of interleukin-6 promoter to facilitate binding of an activator or a repressor. J. Biol. Chem. 282, 33210-33217 (2007). (Pubitemid 350159268)
52. Campeau, E. et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4, e6529 (2009).